237 related articles for article (PubMed ID: 27273937)
1. Epigenetic mechanisms in endometrial cancer.
Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic changes as prognostic predictors in endometrial carcinomas.
Farkas SA; Sorbe BG; Nilsson TK
Epigenetics; 2017 Jan; 12(1):19-26. PubMed ID: 27874289
[TBL] [Abstract][Full Text] [Related]
3. Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer.
Banno K; Nogami Y; Kisu I; Yanokura M; Umene K; Masuda K; Kobayashi Y; Yamagami W; Susumu N; Aoki D
Int J Mol Sci; 2013 Jun; 14(6):12123-37. PubMed ID: 23743825
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in the pathology and epigenetics of endometrial carcinoma.
Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
[TBL] [Abstract][Full Text] [Related]
7. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer.
Piergentili R; Zaami S; Cavaliere AF; Signore F; Scambia G; Mattei A; Marinelli E; Gulia C; Perelli F
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808791
[TBL] [Abstract][Full Text] [Related]
8. Research Progress of DNA Methylation in Endometrial Cancer.
Xu T; Ding H; Chen J; Lei J; Zhao M; Ji B; Chen Y; Qin S; Gao Q
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883495
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.
Bartosch C; Lopes JM; Jerónimo C
Epigenomics; 2017 May; 9(5):737-755. PubMed ID: 28470096
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
Zhou XC; Dowdy SC; Podratz KC; Jiang SW
Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
[TBL] [Abstract][Full Text] [Related]
11. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.
Bartosch C; Lopes JM; Jerónimo C
Epigenomics; 2017 Jun; 9(6):873-892. PubMed ID: 28523964
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208
[TBL] [Abstract][Full Text] [Related]
17. The role of miRNAs in endometrial cancer.
Vasilatou D; Sioulas VD; Pappa V; Papageorgiou SG; Vlahos NF
Epigenomics; 2015; 7(6):951-9. PubMed ID: 26443384
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma.
Yi TZ; Guo J; Zhou L; Chen X; Mi RR; Qu QX; Zheng JH; Zhai L
Cancer Invest; 2011 Jan; 29(1):86-92. PubMed ID: 20874004
[TBL] [Abstract][Full Text] [Related]
19. Update on prognostic markers for endometrial cancer.
Binder PS; Mutch DG
Womens Health (Lond); 2014 May; 10(3):277-88. PubMed ID: 24956294
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients.
Fialkova V; Vidomanova E; Balharek T; Marcinek J; Kudela E; Hanysova S; Visnovsky J; Dobrota D; Hatok J
Gen Physiol Biophys; 2017 Dec; 36(5):521-529. PubMed ID: 29372685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
